Clinical Trial Update: Comparison of TP and TAC Regimens in Neoadjuvant Treatment of TNBC [Phase 2]

View source ↗

Summary

A Phase 2 neoadjuvant trial comparing TP and TAC regimens in triple-negative breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• TAC regimen
• TP regimen

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Triple Negative Breast Cancer | Phase 2 | Status: COMPLETED